Management of Inflammatory Bowel Disease and Pregnancy using Prophylactic Low Dose Low Molecular Weight Heparin and Corticosteroids

Molecular Weight ◽

Bowel Disease ◽

Low Dose ◽

Low Molecular Weight ◽

P064 STANDARD DOSE LOW MOLECULAR WEIGHT HEPARIN PROPHYLAXIS FOR DEEP VENOUS THROMBOSIS AFTER SURGERY FOR INFLAMMATORY BOWEL DISEASE

Journal of Crohn s and Colitis Supplements ◽

10.1016/s1873-9954(07)70076-9 ◽

2007 ◽

Vol 1 (1) ◽

pp. 20

Author(s):

C. Ruffolo ◽

F. Pilon ◽

V. Pengo ◽

G. Romanato ◽

M. Scarpa ◽

...

Keyword(s):

Molecular Weight ◽

Venous Thrombosis ◽

Deep Venous Thrombosis ◽

Bowel Disease ◽

Standard Dose ◽

Low Molecular Weight ◽

Inflammatory Bowel ◽

Heparin Prophylaxis

Tu1798 – Low Molecular Weight Heparin (LMWH) Compared with Unfractionated Heparin (UFH) for Venous Thromboembolism (VTE) Prophylaxis in Hospitalized Patients with Inflammatory Bowel Disease (IBD)

Gastroenterology ◽

10.1016/s0016-5085(19)39784-7 ◽

2019 ◽

Vol 156 (6) ◽

pp. S-1128

Author(s):

Jose R. Ruiz ◽

Joao Filipe G. Monteiro ◽

Erick A. Argueta ◽

Sean Fine

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Unfractionated Heparin ◽

Bowel Disease ◽

Hospitalized Patients ◽

Low Molecular Weight ◽

Vte Prophylaxis ◽

Deep Venous Thrombosis After Surgery for Inflammatory Bowel Disease: Is Standard Dose Low Molecular Weight Heparin Prophylaxis Enough?

World Journal of Surgery ◽

10.1007/s00268-010-0490-8 ◽

2010 ◽

Vol 34 (7) ◽

pp. 1629-1636 ◽

Cited By ~ 17

Author(s):

Marco Scarpa ◽

Fabio Pilon ◽

Vittorio Pengo ◽

Giovanna Romanato ◽

Cesare Ruffolo ◽

...

Keyword(s):

Molecular Weight ◽

Venous Thrombosis ◽

Deep Venous Thrombosis ◽

Bowel Disease ◽

Standard Dose ◽

Low Molecular Weight ◽

Inflammatory Bowel ◽

Heparin Prophylaxis

Low molecular weight heparin (LMWH) in chronic inflammatory bowel disease (IBD) unresponsive to standard therapy: Clinical outcomes and risk factors of thromboses

Digestive and Liver Disease ◽

10.1016/s1590-8658(00)80657-x ◽

2000 ◽

Vol 32 ◽

pp. A120

Author(s):

C. Alvisi ◽

G. Gamba ◽

P. Noris ◽

F. Torello Viera ◽

S. Bartolozzi ◽

...

Keyword(s):

Risk Factors ◽

Molecular Weight ◽

Bowel Disease ◽

Standard Therapy ◽

Chronic Inflammatory Bowel Disease ◽

Low Molecular Weight ◽

Inflammatory Bowel ◽

Chronic Inflammatory Bowel

Unfractionated or low molecular weight heparin for induction of remission in ulcerative colitis: A cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials

Inflammatory Bowel Diseases ◽

10.1002/ibd.21776 ◽

2011 ◽

Vol 17 (9) ◽

pp. 1979-1986 ◽

Cited By ~ 20

Author(s):

Nilesh Chande ◽

John K. MacDonald ◽

Josh J. Wang ◽

John W.D. McDonald

Keyword(s):

Systematic Review ◽

Ulcerative Colitis ◽

Molecular Weight ◽

Randomized Trials ◽

Low Molecular Weight ◽

Functional Bowel Disorders ◽

Bowel Disorders ◽

Su1374 Low Dose Azathioprine With Allopurinol Co-Therapy Without Metabolite Profiling Is More Effective and Safer Than Full Dose Azathioprine for Inflammatory Bowel Disease Patients: A Large UK Centre Experience

Gastroenterology ◽

10.1016/s0016-5085(14)61617-6 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-450-S-451 ◽

Cited By ~ 1

Author(s):

Panagiotis Stamoulos ◽

Evangelos Stournaras ◽

Clare Bull ◽

Matthew Cowan ◽

Gary Mackenzie ◽

...

Keyword(s):

Bowel Disease ◽

Metabolite Profiling ◽

Low Dose ◽

Full Dose ◽

P120 - Safety and efficacy of total dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease

Journal of Crohn s and Colitis ◽

10.1016/s1873-9946(09)60147-1 ◽

2009 ◽

Vol 3 (1) ◽

pp. S58

Author(s):

P. Oustamanolakis ◽

I. Koutroubakis ◽

C. Karakoidas ◽

G.J. Mantzaris ◽

E. Kouroumalis

Keyword(s):

Molecular Weight ◽

Iron Deficiency ◽

Deficiency Anemia ◽

Low Molecular Weight ◽

Iron Dextran ◽

Safety And Efficacy ◽

Dose Infusion ◽

Inflammatory Bowel ◽

Low Molecular Weight Iron

Low dose thioguanine guided by therapeutic drug monitoring is a safe and effective alternative in inflammatory bowel disease patients intolerant to conventional thiopurines

Internal Medicine Journal ◽

10.1111/imj.15639 ◽

2021 ◽

Author(s):

A. Eqbal ◽

A. Martin ◽

J.D. Doecke ◽

D. Patrick

Keyword(s):

Therapeutic Drug Monitoring ◽

Bowel Disease ◽

Drug Monitoring ◽

Low Dose ◽

Effective Alternative ◽

Therapeutic Drug ◽

Low-dose biologics to treat inflammatory bowel disease. Ready for prime time?

Digestive and Liver Disease ◽

10.1016/j.dld.2019.02.005 ◽

2019 ◽

Vol 51 (4) ◽

pp. 609-610

Author(s):

Dario Sorrentino

Keyword(s):

Bowel Disease ◽

Low Dose ◽

Prime Time ◽

A Comparison of Low-Dose Heparin with Low-Molecular Weight Heparin (LMWH) as Prophylaxis against Venous Thromboembolism after Major Trauma

50 Landmark Papers ◽

10.1201/9780429316944-91 ◽

2019 ◽

pp. 285-287

Author(s):

Ara Feinstein

Keyword(s):

Molecular Weight ◽

Venous Thromboembolism ◽

Major Trauma ◽

Low Dose ◽

Low Molecular Weight ◽

Dose Heparin ◽

Low Dose Heparin